HUNTER CAPITAL AB

Hunter Capital AB Stock

Stocks

HUNTER

SE0022087649

End-of-day quote NORDIC GROWTH MARKET 2026-09-29			5-day change	1st Jan Change
10.35 ^SEK	-7.17%		-.--%	-26.07%

09-17	Hunter Capital buys shares in C100 for $0.5m (R)	FW
09-10	C100 returns to its regular place on Spotlight	FW

Valuation: Hunter Capital AB

Market Cap	46.99M 4.72M 4.22M 3.91M 3.54M 6.62M 449M 6.73M 18.59M 235M 17.72M 17.34M 744M	P/E 2024	2.2x	P/E 2025	1.92x
Enterprise Value	45.81M 4.6M 4.11M 3.81M 3.45M 6.45M 438M 6.56M 18.12M 229M 17.27M 16.9M 725M	EV / Sales 2024	11.4x	EV / Sales 2025	41.1x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: Hunter Capital AB

NORDIC GROWTH MARKETSEK

Markets		Quality
NORDIC GROWTH MARKET	HUNTER	End-of-day quote
Deutsche Boerse AG	2DD0	Delayed

Latest news: Hunter Capital AB

09-17	Hunter Capital buys shares in C100 for $0.5m (R)	FW
09-10	C100 returns to its regular place on Spotlight	FW
09-10	Hunter Capital cuts its stake in C100, falls below 90%	FW
09-08	Hunter Capital reaches over 90 percent in C100 after mandatory cash offer	FW
09-07	Hunter Capital reaches over 90 percent of the shares in C100	FW
08-28	Hunter Capital AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-28	Hunter Capital posted a lower profit in the second quarter	FW
08-24	C100's board advises against Hunter Capital's offer	FW
07-31	Hunter Capital raises its offer for C100 after correction	FW
07-29	Hunter Capital submits mandatory offer for C100 (update)	FW
07-29	Hunter Capital makes a mandatory offer for C100	FW
07-15	Hunter Capital cuts stake in C100 ahead of mandatory takeover offer	FW
07-07	Hunter Capital sells shares in C100 for just over 3 million kronor	FW

Press Releases: Hunter Capital AB

07-06	Hunter Capital RTO 1 : Hunter Capital RTO 1 AB (publ) provides an update on the planned transaction with ResoTher Pharma A/S	PU
03-30	Hunter Capital RTO 1 : Hunter Capital RTO 1 signs Letter of Intent for reverse takeover of Nordic Phase 2 biotech company at an implied valuation of SEK 365–405 million	PU
25-09-05	Hunter Capital: Hunter Capital AB (publ) acquires warrants and shares in SynAct Pharma AB (publ) from Heights Capital Management	PU

More press releases

Quotes and Performance

1 day	-7.17%
1 month	-2.36%
3 months	-6.76%
6 months	+3.71%
Current year	-26.07%

Price Extremes

1 month	10.35		11.95
Current year	7.98		17.6
1 year	7.98		34.4
3 years	2		34.4
5 years	2		214.5
10 years	2		940

Managers and Directors: Hunter Capital AB

Manager	Title	Age	Since
Jacob Alexander Eriksson CEO	Chief Executive Officer	34	2024-09-01

Director	Title	Age	Since
David Olhed BRD	Director/Board Member	42	2021-05-20
Oliver Alexander Aleksov CHM	Chairman	32	2022-12-31
Jacob Alexander Eriksson BRD	Director/Board Member	34	2022-12-31

Financials

	2024	2025
Net sales	1.04M 105K 93.78K 86.77K 78.56K 147K 9.98M 149K 413K 5.22M 394K 385K 16.52M	1.52M 152K 136K 126K 114K 214K 14.51M 217K 600K 7.59M 572K 560K 24.02M
Net income	8.25M 829K 741K 686K 621K 1.16M 78.88M 1.18M 3.26M 41.26M 3.11M 3.05M 131M	33.13M 3.33M 2.98M 2.75M 2.49M 4.67M 317M 4.74M 13.1M 166M 12.49M 12.22M 524M
Net Debt	-6.21M -624K -558K -516K -467K -874K -59.35M -889K -2.46M -31.04M -2.34M -2.29M -98.28M	-1.19M -119K -107K -98.8K -89.45K -167K -11.36M -170K -470K -5.94M -448K -439K -18.82M

Projected Income Statement - Annual - Hunter Capital AB

* Estimated data More financial data

Company Profile

Employees

1

Sector

-

More about the company

Stock Market
Stocks
HUNTER Stock

The best tools reserved for subscribers to boost the performance of your investments!

×